FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

Revogene

K Number: K222779 · Decision Jan 26, 2023
Classifications
1
FEI Numbers
78
Registration Numbers
78
Same Product Code
13
Applicant Total
38
Review Days
134

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
Revogene
K Number
K222779
Device Class
FDA class 2
Clearance Type
Special
Regulation Number
862.2570
Medical Specialty
Clinical Chemistry
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Meridian Bioscience, Inc.
Date Received
September 14, 2022
Decision Date
January 26, 2023
Product Code
OOI
Advisory Committee
Clinical Chemistry
Review Advisory Committee
MI
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
OOI Real Time Nucleic Acid Amplification System

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (OOI), ordered by most recent decision date.

View all

Other Clearances by Meridian Bioscience, Inc.

K Number Device Name
K243922 Revogene
K230901 Premier HpSA Flex (619096)
K222829 Curian® Shiga Toxin
K220480 Revogene
K210976 Curian Campy
K192817 Curian HpSA, Curian Analyzer
DEN180040 Alethia CMV DNA Amplification Assay, Alethia CMV External Control Kit
K182559 PREMIER Platinum HpSA PLUS
K163273 TRU Legionella
K160829 illumigene Mycoplasma Direct DNA Amplification Assay, illumigene Mycoplasma Direct External Controls, illumipro-10
Search all 38 clearances from Meridian Bioscience, Inc. →